Who owns Thompson Craig B.?

No ownership or control links for Thompson Craig B. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Thompson Craig B.'s risk level?

WhiteIntel flags Thompson Craig B. as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Thompson Craig B. appear across sources?

Thompson Craig B. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Thompson Craig B.

Name: Thompson Craig B. — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Thompson Craig B., Person, US

Thompson Craig B. — US person (sec:0001423419). 4 holdings. Every claim linked to its source.

controls 4 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 4 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 4 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Thompson Craig B.
- REGENERON PHARMACEUTICALS, INC.· director· via SEC EDGAR (Form 3/4/5)
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.· director· via SEC EDGAR
- Merck & Co., Inc.· director· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Thompson Craig B. — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Thompson Craig B. is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Thompson Craig B. is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

3 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Also holds roles at 51 other companies
- Girshick Birgitofficer
- FOSTER JAMES Cofficer
- LaPlume Joseph Wofficer
●
Merck & Co., Inc.
Also holds roles at 110 other companies
- Oosthuizen Johannes Jacobusofficer
- Williams David Michaelofficer
- THULIN INGE Gdirector
●
REGENERON PHARMACEUTICALS, INC.
Also holds roles at 43 other companies
- Schenkein David Pdirector
- COLES N ANTHONYdirector
- Zoghbi Huda Ydirector

3 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Thompson Craig B.?: No ownership or control links for Thompson Craig B. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Thompson Craig B.'s risk level?: WhiteIntel flags Thompson Craig B. as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Thompson Craig B. appear across sources?: Thompson Craig B. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Thompson Craig B.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…